Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 4Pain, Postoperative 2Neoplasms 2Agnosia 2Recurrence 1Postoperative Cognitive Complications 1Non-Muscle Invasive Bladder Neoplasms 1Neoplastic Cells, Circulating 1Myofibroma 1Melanoma 1Liver Neoplasms 1Leiomyoma 1Inflammatory Bowel Diseases 1Diverticulitis 1Delirium 1Colonic Neoplasms 1Cancer Surgery 1

Interventions

Tea 3Polyethylene Glycols 3Infliximab 3MEDI2070 2Lidocaine 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2sodium phosphate 1prucalopride 1polyethylene glycol 400 1picosulfate sodium 1golimumab 1cabozantinib 1Surgical Tape 1Standard of Care 1Spectrum Analysis, Raman 1Specimen Handling 1Pneumococcal Vaccines 1Platinum Compounds 1Passive Cutaneous Anaphylaxis 1Papillomavirus Vaccines 1Oxygen 1Nivolumab 1Neomycin 1Narrow Band Imaging 1Morphine 1Metronidazole 1Medical Marijuana 1Laparoscopy 1Ipilimumab 1Indocyanine Green 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Inflammatory Bowel Diseases × Anesthesia, Spinal × Clear all
NCT01477190 2011-11-28

Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 1/2 Completed
40 enrolled
Gastrointestinal

Colonic Neoplasms, Diverticulitis, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡